OCUGEN, INC. Depreciation
OCUGEN, INC. (OCGN) reported Depreciation of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- OCUGEN, INC. depreciation for the quarter ending 2026-06-30 was $600.00K, a 0.00% change year-over-year.
- OCUGEN, INC. depreciation for the quarter ending 2026-03-31 was $600.00K, a 0.00% change year-over-year.
- OCUGEN, INC. depreciation for the quarter ending 2025-06-30 was $600.00K.
- OCUGEN, INC. depreciation for the quarter ending 2025-03-31 was $600.00K.
- OCUGEN, INC. depreciation for fiscal 2025 was $2.40M, a 26.32% increase from fiscal 2024.
- OCUGEN, INC. depreciation for fiscal 2024 was $1.90M, a 171.43% increase from fiscal 2023.
- OCUGEN, INC. depreciation for fiscal 2023 was $700.00K.
- OCUGEN, INC. depreciation for fiscal 2021 was $200.00K, a 100.00% increase from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-06 | $1.20M 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $600.00K 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | $2.40M 10-K · filed 2026-03-04 | |||||||
| 2025-06-30 | $600.00K 10-Q · filed 2026-08-06 | $1.20M 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | $600.00K 10-Q · filed 2026-05-08 | |||||||
| 2024-12-31 | $1.90M 10-K · filed 2026-03-04 | |||||||
| 2023-12-31 | $700.00K 10-K · filed 2025-03-05 | |||||||
| 2021-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $149.00K derived: sum of 2 quarters · filed 2022-02-28 | $198.00K derived: sum of 3 quarters · filed 2022-02-28 | $200.00K 10-K · filed 2022-02-28 | ||||
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-09 | $149.00K derived: sum of 2 quarters · filed 2021-11-09 | $151.00K 10-Q · filed 2021-11-09 | $235.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $93.00K 10-Q · filed 2021-08-06 | $135.00K derived: sum of 3 quarters · filed 2022-02-28 | $154.80K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-03-31 | $44.00K 10-Q · filed 2021-05-07 | $86.00K derived: sum of 2 quarters · filed 2022-02-28 | $105.80K derived: sum of 3 quarters · filed 2022-02-28 | $125.80K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $61.80K derived: sum of 2 quarters · filed 2022-02-28 | $81.80K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K 10-K · filed 2022-02-28 | $102.11K 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $19.80K 10-Q · filed 2021-11-09 | $39.80K derived: sum of 2 quarters · filed 2021-11-09 | $58.00K 10-Q · filed 2021-11-09 | $57.56K 10-Q · filed 2020-11-06 | $123.17K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $38.00K 10-Q · filed 2021-08-06 | $37.76K 10-Q · filed 2020-08-14 | $103.37K derived: sum of 3 quarters · filed 2022-02-28 | $118.74K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-07 | $18.28K 10-Q · filed 2020-05-08 | $83.37K derived: sum of 2 quarters · filed 2022-02-28 | $98.74K derived: sum of 3 quarters · filed 2022-02-28 | $103.40K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $65.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $80.74K derived: sum of 2 quarters · filed 2022-02-28 | $85.40K derived: sum of 3 quarters · filed 2022-02-28 | $100.00K 10-K · filed 2022-02-28 | $60.61K 10-K · filed 2020-03-27 | |||
| 2019-09-30 | $15.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $20.02K derived: sum of 2 quarters · filed 2020-11-06 | $34.63K 10-Q · filed 2020-11-06 | $49.20K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $4.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $19.26K 10-Q · filed 2020-08-14 | $33.83K derived: sum of 3 quarters · filed 2020-08-14 | $133.83K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $14.60K 10-Q · filed 2020-05-08 | $6.00K 10-Q · filed 2019-05-15 | $29.17K derived: sum of 2 quarters · filed 2020-05-08 | $129.17K derived: sum of 3 quarters · filed 2020-05-08 | $329.17K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $14.57K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $114.57K derived: sum of 2 quarters · filed 2020-03-27 | $314.57K derived: sum of 3 quarters · filed 2020-03-27 | $49.62K 10-K · filed 2020-03-27 | $450.00K 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $100.00K 10-Q · filed 2018-11-08 | $300.00K derived: sum of 2 quarters · filed 2018-11-08 | $35.05K 10-Q · filed 2019-11-12 | $364.00K 10-Q · filed 2018-11-08 | $828.00K derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2018-06-30 | $200.00K 10-Q · filed 2018-08-09 | $20.65K 8-K/A · filed 2019-10-07 | $322.00K 10-Q · filed 2018-08-09 | $728.00K derived: sum of 3 quarters · filed 2019-05-15 | $1.13M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2018-03-31 | $172.00K 10-Q · filed 2019-05-15 | $528.00K derived: sum of 2 quarters · filed 2019-05-15 | $928.00K derived: sum of 3 quarters · filed 2019-05-15 | $1.33M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | $356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $756.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.16M derived: sum of 3 quarters · filed 2019-03-22 | $1.53M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $400.00K 10-Q · filed 2018-11-08 | $389.00K 10-Q · filed 2017-11-09 | $800.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.18M 10-Q · filed 2018-11-08 | $1.60M derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $400.00K 10-Q · filed 2018-08-09 | $394.00K 10-Q · filed 2017-08-10 | $789.00K 10-Q · filed 2018-08-09 | $1.20M derived: sum of 3 quarters · filed 2018-08-09 | $1.60M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $394.00K 10-Q · filed 2018-05-10 | $800.00K derived: sum of 2 quarters · filed 2018-05-10 | $1.20M derived: sum of 3 quarters · filed 2018-05-10 | $1.64M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $810.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.24M derived: sum of 3 quarters · filed 2018-03-15 | $1.67M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $404.00K 10-Q · filed 2017-11-09 | $836.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.27M 10-Q · filed 2017-11-09 | $1.70M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $432.00K 10-Q · filed 2017-08-10 | $862.00K 10-Q · filed 2017-08-10 | $1.29M derived: sum of 3 quarters · filed 2017-08-10 | $1.71M derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | $430.00K 10-Q · filed 2017-05-11 | $862.00K derived: sum of 2 quarters · filed 2017-05-11 | $1.28M derived: sum of 3 quarters · filed 2017-05-11 | $1.67M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $846.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.24M derived: sum of 3 quarters · filed 2017-03-16 | $1.61M 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | $414.00K 10-Q · filed 2016-11-10 | $811.00K derived: sum of 2 quarters · filed 2016-11-10 | $1.18M 10-Q · filed 2016-11-10 | $1.43M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $397.00K 10-Q · filed 2016-08-11 | $768.00K 10-Q · filed 2016-08-11 | $1.01M derived: sum of 3 quarters · filed 2016-08-11 | $1.18M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $371.00K 10-Q · filed 2016-05-12 | $615.00K derived: sum of 2 quarters · filed 2016-05-12 | $784.00K derived: sum of 3 quarters · filed 2016-05-12 | $944.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $413.00K derived: sum of 2 quarters · filed 2016-03-10 | $573.00K derived: sum of 3 quarters · filed 2016-03-10 | $726.00K 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | $169.00K 10-Q · filed 2015-11-12 | $329.00K derived: sum of 2 quarters · filed 2015-11-12 | $482.00K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $160.00K 10-Q · filed 2015-08-12 | $313.00K 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | $153.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |